Novartis is taking its digital efforts up a notch with new tools designed to help multiple sclerosis patients understand their illness.

AbbVie’s Humira finished the last month of 2016 in much the same way it did most of the year—as the No. 1 national TV ad spender among pharma brands.

The FDA’s promotional enforcement squad wasn’t very active in 2016—until December, that is. This month, they've cited six drugmakers, more than half the…

Avanir Pharmaceuticals has launched its first branded campaign for Nuedexta to treat pseudobulbar affect, while it also retires the disease awareness ad it…

Cancer drug websites load up on numbers about benefits, but tread lightly on side effects, an FDA study found. It’s the latest to flag weaknesses in cancer…

Drugs may be costly, but they save money. That's the latest argument in BIO's image advertising, designed to answer a public outcry over rising drug…

Allergan knows people inherit lots of traits from their families--and they don't love all of them. That’s the theme of two brand-new DTC ads for chin-fat-…

Diabetes drugmakers are feeling the pressure from price-conscious payers and a slew of new competition. Maybe that's why DTC advertising in the category…

DTC Advertising